Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (510,285)	$ (1,688,322)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation	23,808	13,242
Amortization of intangible assets	78,005	81,237
Change in fair value of convertible note	0	(141,991)
Amortization of capitalized contract costs	38,665	37,529
Reserve for inventory	0	500,000
Operating leases right-of-use assets	13,686	66,132
Share and warrant-based compensation for employees and consultants	47,790	59,373
Stock based directors’ fees	9,003	12,002
Bad debts	100,000	0
Change in assets and liabilities:
Accounts receivable	399,749	(898,881)
Due from factor	91,070	(33,000)
Capitalized contract costs	(158,005)	(8,739)
Inventory	5,545	6,554
Prepaid expenses and other	(63,513)	2,219
Accounts payable	(116,012)	88,040
Accrued liabilities	(104,257)	(135,417)
Deferred revenue	455,868	178,755
Operating lease liabilities	(14,033)	(67,544)
Net cash provided by (used in) operating activities	297,084	(1,928,811)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(1,869)	0
Net cash used in investing activities	(1,869)	0
CASH FLOW FROM FINANCING ACTIVITIES:
Offering costs	(13,470)	0
Proceeds for exercise of warrants	1,400	0
Repayment of government loan	(41,821)	(34,289)
Net cash used in financing activities	(53,891)	(34,289)
Effect of exchange rate changes	(62,275)	49,913
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	179,049	(1,913,187)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	511,400	2,635,522
CASH AND CASH EQUIVALENTS, END OF PERIOD	690,449	722,335
Cash paid for:
Interest	$ 1,356	$ 56,919